Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vuk Zdinjak

South African Medical Marijuana Dispensaries Completes Acquisition Of Protext Mobility

Republic of South Africa Medical Marijuana Dispensaries Acquisitions LLC (“RSAMMDA.LLC”) has closed on the acquisition of Protext Mobility, Inc (OTCPK:TXTM) in a share exchange whereby 100% of capital stock in RSAMMDA.LLC will be exchanged for preferred stock in Protext.

RSAMMDA.LLC. is a jointly owned company focused on acquisitions with two principals, Dylon Du Plooy and Dr. Ahmed Jamaloodeen (“Dr. J”) who represent the South African business entities of RSAMMD and Leeds Boerdery. RSAMMD is a South African pioneer in the research, cultivation, production and distribution of medical cannabis and cannabinoids. Leeds Boerdery, controlled by Dr. J owns the 5000 Hectare New Castle Farm as well as federally issued cannabis and hemp licenses issued by the Government of South Africa.

RSAMMD management has taken over the daily operations of Protext headed by Du Plooy as CEO and director, and Dr. Jamaloodeen as president and chairman of the board.
“This transaction has been a long time in the making. For the past couple years we have been focused on building our operations in South Africa and globally, where have built an extensive infrastructure and global cannabis/hemp business. During this period of time, we have invested heavily in building a significant cannabis/hemp operation to facilitate complete seed to sale, R&D, global off-take agreements for end product as well as all the extraction infrastructure needed to create what we believe to be some of the highest quality hemp and cannabis on the planet. In South Africa right now, we have just completed our semi-annual grow. RSAMMD in joint venture with Leeds Boerdery, cultivated hemp and cannabis crops this past season on a combined 1000+ hectares. All of this is done under federally issued permits and licenses to grow, import/export hemp and cannabis, as well as research permits for conducting testing of final products for human consumption and medicinal benefits," said Du Plooy.
“Over the coming days and weeks, we will be sharing our immediate term road map and long-term plans we are developing for Protext which should translate into increasing shareholder value. These plans include adding other valuable assets to the company which complement the core business, and executing on commercializing the proprietary live plant extraction technology as well as deploying our crypto platform, with a TXTM token which we are excited to rollout very soon.” concluded Du Plooy.”

Photo by Diyahna Lewis on Unsplash

 

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.